drug
naftifine hydrochloride
Marketedupdated 4mo agoby Legacy Pharma Solutions
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying naftifine hydrochloride
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 31, 2033
~6.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (6)
- Jan 31, 2033formulationUS 10166205
- Jan 31, 2033formulationUS 10166206
- Jan 31, 2033formulationUS 10695303
- Jan 31, 2033formulationUS 10729667
- Jan 31, 2033formulationUS 8778365
- Jan 31, 2033method-of-use (U-540)US 9161914
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that